Cat. No.: DIA-0243218
Product Information | |
---|---|
CAS No. | 844439-96-9 |
Target | Insulin Receptor |
Product Description | Insulin degludec is an ultra-long-acting form of insulin used for the research of hyperglycemia caused by type 1 and type 2 dabetes. Insulin degludec shows binding efficiency with an IC50 value of 19.59 nM for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes. |
Format & Storage | |
---|---|
Format | Solid |
Purity | 99.94% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Solubility Overview | 0.1 M HCL : 50 mg/mL H2O : 50 mg/mL |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.